Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

N.C. Bill Gives Students 'Vital Access' To Accurate Sex Education Instruction, Editorial States
A bill (S. 221) approved by the North Carolina Legislature that would require a public school sex education curriculum covering abstinence, contraception and sexually transmitted infections "will be the most comprehensive and science-based approach the state has used" for sex education, a Charlotte Observer editorial states, adding that Gov. Bev Perdue (D) "should sign it." The bill would require all public school districts in the state to teach a curriculum that focuses on abstinence but also includes information on preventing pregnancy and STIs. Parents would be able to have their children removed from the comprehensive portions of instruction. According to the editorial, the measure "still gives parents a choice in deciding what kind of sex education their children will receive." The editorial adds, "It also finally provides a curriculum that gives N.C. students vital access to age-appropriate, science-based information critical to their health, safety and well-being," which is "the kind of information that can help them make smart choices in serious situations."Parents are "often the best people for kids to turn to for advice and information" on sex, but "not all children have parents who can provide it, or are even willing to," and "not all children [who] go to their parents adhere to their advice," the editorial states. It continues, "The schools provide another avenue to get this critical advice and information -- and state lawmakers are right to make it available." According to the Observer, North Carolina has the ninth-highest teenage pregnancy rate in the U.S., and about "20,000 teenagers will get pregnant in North Carolina this year." A "comprehensive, science-based education program can help reduce the number of unintended teen pregnancies" and help reduce the spread of STIs, the editorial says. It concludes, "By reaching agreement on this matter, state lawmakers have given the children of this state vital tools to safeguard their health and welfare. ... Perdue should sign this bill and make it law" (Charlotte Observer, 6/26).
generic viagra online
Australia's Chief Nurse Wins ICN Presidency
The Australian Nursing Federation (ANF) warmly congratulated Rosemary Bryant - Australia"s Chief Nursing and Midwifery officer - on her appointment as President of the International Council of Nurses (ICN).
News of the day
Canada And China Renew Plan Of Action For Cooperation In Health For 2009-2011
The Honourable Leona Aglukkaq, Minister of Health, and Dr. Chen Zhu, Minister of Health for the People"s Republic of China, today signed a Plan of Action for continued cooperation between the two countries on health priorities of mutual concern. The signing ceremony followed discussions among senior Canadian and Chinese health officials and experts on a range of health issues, including strengthening and reform of health-care systems, primary health care and food safety.
Nutrition

Israeli Startup CLT Partners With Dutch Erasmus Medical Centre To Develop A Cure For Atrial Fibrillation

Today, the Israeli medtech startup company CLT Ltd. announced the establishment of Closed Loop Therapies (CLT) BV - a joint venture between Erasmus University Medical Centre (Rotterdam, the Netherlands), a highly prominent medical institute in Europe, and CLT Israel. The joint venture aims to develop and commercialise a novel therapeutic system, consisting of an arrhythmia-detecting drug pump combined with a unique drug, for automatic and immediate treatment of emerging atrial fibrillation (AF). Market size is estimated at 2.5-3 billion Euro, annually. AF, the most common cardiac arrhythmia, causes substantial morbidity, mortality, decreased quality of life and considerable healthcare expenses. Existing AF treatment methods, whether electrical, surgical or pharmacological, have proven largely inadequate due to limited efficacy and/or potential for adverse effects. The system is based on a breakthrough discovery by two of the founders of CLT, Professor Eli Ovsyshcher of Ben Gurion University (formerly Head of Pacing and Arrhythmia Services at Soroka Medical Centre) and Dr Ilya Fleidervish of the Hebrew University. This discovery led to a highly effective method for pharmacological conversion of AF, employing brief bolus injections of rapidly hydrolysable cholinergic agonists (RHCA) into the bloodstream. To further this discovery, CLT Ltd. initiated collaboration with Professor Luc Jordaens, Head of Electrophysiology at the Thorax Centre of Erasmus MC and a leading expert in cardiac arrhythmia. "This joint venture is first of its kind between an Israeli medical startup and a Dutch centre of excellence," says Dr. Dan Gelvan, co-founder of CLT Ltd. and director of CLT BV. "It opens opportunities for Israeli early-stage companies with complex technologies to establish an "incubation stage" presence in Europe and obtain invaluable professional and financial support." Steven Tan, Business Developer of Erasmus MC, comments: "We are proud to welcome CLT as the first Israeli company to join our incubator programme. We hope it will be the first of many such international collaborations." According to Dr. Gelvan, the inception of the joint venture with Erasmus MC was initiated by Dr. Binah Baum via her extensive connections with European incubators and bioregions. It was supported and facilitated by Kurtz Marketing & Management of Rotterdam, a business development consultancy in life sciences and high-tech, and received strategic assistance from Mr Wim van Sluis, Partner at Daamen & Van Sluis, and former Alderman for Economic Affairs in Rotterdam. This initiative was backed by TechnoPartner, an intergovernmental agency that supports new technological business ventures in the Netherlands. CLT BV will be led by Ivo Timmermans, MD MBA, a highly accomplished veteran of the European pharmaceutical industry. Dr Timmermans joined CLT BV on March 1, 2009 after holding management positions at GlaxoWellcome, BASF Pharma, Rhein Biotech and Phico Therapeutics. Israeli Startup CLT


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009